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In the United States, 4490 new malignant vulvar tumors and 950
deaths are expected secondary to vulvar malignancy in 2012 (Siegel
et al., 2012). The most common histologic type is the squamous cell
carcinoma. The presence of inguinofemoral lymph node metastasis
is the hallmark of FIGO stage III vulvar cancer. At this stage, 5-year
survival rates vary from 20% to 60% depending on the number and
location of involved lymph nodes (Rutledge et al., 1991). Clinical pre-
diction of lymph node spread can be inaccurate, so lymph node status
is best determined surgically (Micheletti et al., 1990). Systematic,
complete inguinofemoral lymphadenectomy is the historical gold
standard for evaluating metastasis (Micheletti et al., 1990). However,
this procedure carries a high complication rate, including lymphede-
ma, especially if chemoradiation is needed due to pathologically
proven metastases (Homesley et al., 1986).
Along with clinical assessment, ﬂuorine-18, deoxy-2-ﬂuoro-D-glucose
positron emission tomography (PET)–computerized tomography (CT)
(PET–CT) scan can be used preoperatively to diagnose possible regional
inguinofemoral lymph node or distant metastasis (Cohn et al., 2002). In
the absence of inguinofemoral metastasis on a PET–CT scan, the surgical
approach is to perform radical vulvectomy with systematic completeisconsin School of Medicine and Public
, WI 53717, USA. Fax: +1 608 265 6572.
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metastasis is found in the inguinofemoral lymph node basin by PET–CT
scan, many surgeons will debulk the positive lymph node, and follow
the surgery by adjuvant chemoradiation therapy.
We present a patient with invasive vulvar carcinoma with bilater-
al inguinofemoral lymph nodes that are both clinically palpable and
PET–CT scan positive. Removal of the inguinofemoral lymph nodes
was then performed. This case demonstrates limitations of this radio-
logic technique.Case
A 34 year-old female presented with a six-month history of vulvar
pain and discharge. Vulvar examination revealed a 10 cm bilateral ulcer-
atedmass, extending to the distal portion of the vagina and surrounding
the anus. She was then referred to the university gynecologic oncology
clinic.
At the clinic, a thorough examination revealed the mass extending
from the lower half of the left labia through the perineal body, to the
lower half of the right labia. It also involved the lower half of the pos-
terior vaginal wall and the skin around the anus. Although it was
close to the anal sphincter, it did not invade the rectovaginal septum
or the anal sphincter itself. Examination also showed two palpable
and ﬁrm inguinal lymph nodes in the left groin measuring 1 and
2 cm in diameter and a 1 cm lymph node on the right side. A punch
biopsy of the primary lesion was taken that later revealed invasive
squamous cell carcinoma.
PET–CT scan highlighted the vulvar lesion as well as several promi-
nent bilateral inguinal lymphnodes— allwith positive uptake, suggesting
inguinofemoral metastasis without apparent distant metastasis (Fig. 1).
The initial diagnosis was a T3 vulvar lesion with bilateral lymph node
involvement.
Due to the extent of the vulvar lesion and close proximity to the
anal sphincter, the decision was made to surgically debulk the
inguinofemoral lymph nodes without operating on the primary
tumor. Surgery would be followed by primary chemoradiation thera-
py to the vulvar mass and to both inguinofemoral lymph node basins.
Debulking of the lymph nodes was uncomplicated. Four enlarged
nodes were found on the left, the largest being 2.1 cm. On the right,
there were 3 small palpable lymph nodes approximately 0.5 to 1 cm
in size. All suspicious lymph nodes were removed. Because of the
multiplicity and size of the affected nodes, a complete bilateral
Fig. 1. PET positive lymph node in the left inguinofemoral region.
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node debulking. No frozen section analysis was deemed necessary.
Final pathologic examination revealed eleven left inguinal lymph
nodes, ranging in size from 0.3–2.1 cm, all negative for metastatic
cancer (Fig. 2). On the right side, there were nine inguinal lymph
nodes, ranging in size from 0.5–1.5 cm, which were also all negativeFig. 2. Histologically negative PET positive lymph node.for metastatic cancer. The patient's ﬁnal diagnosis was stage II vulvar
squamous cell carcinoma.Comment
Our case details a patient with extensive vulvar cancer and clini-
cally large and suspicious bilateral inguinofemoral lymph nodes
consistent with metastatic disease and conﬁrmed by PET–CT scan.
Pathologically, however, none of the lymph nodes showed cancer me-
tastasis. This report highlights the limitations of PET–CT scanning in
its ability to predict lymph node metastasis, even in the setting of
clinically large and suspicious nodes.
Since the staging of vulvar cancer is performed surgically, it de-
pends on the result of a systematic and complete inguinofemoral
lymphadenectomy. Metastasis to these lymph nodes signiﬁes stage
III vulvar cancer. It is known that 10% to 20% of patients with disease
conﬁned to the vulva will show clinically occult inguinofemoral
lymph node metastases, depending mainly on the depth of invasion
of the primary site (Binder et al., 1990). However, inguinofemoral
lymphadenectomy while imperative to the evaluation of lymph nodes,
has a relatively high complication rate. To lower the incidence of com-
plications, three strategies have been suggested: intraoperative frozen
section analysis of suspicious lymph nodes (and omission of full lymph-
adenectomy) (McGee and Covens, 2009), sentinel lymph node (SLN)
dissection (McGee and Covens, 2009), and PET–CT scan to detect me-
tastasis prior to surgery (Basu et al., 2009).
Frozen section has good accuracy in evaluation of lymph nodes, but
its utilization is generally limited to those incidences when the surgeon
palpates a suspicious lymph node during surgery (Brunner et al., 2008).
The second strategy of SLN dissection is currently undergoing clinical
investigation. Recent studies show evidence indicating that it appears
safe to omit inguinofemoral lymphadenectomy in the case of a negative
SLN, with a high negative predictive value (Oonk et al., 2010). SLN dis-
section has not yet been universally adopted as a standard of care in the
United States (van der Steen et al., 2010). The third strategy (preopera-
tive use of a PET–CT scan) can help modify the technique of
inguinofemoral lymphadenectomy. It is adopted in our practice in com-
bination with intraoperative frozen section analysis. It also helps quan-
tify distant occult metastasis if present.
The principle of PET scanning is based upon human tissue uptake
of a glucose analog that has been tagged with a positron-emitting iso-
tope (ﬂuorine-18). This process is intensiﬁed in malignant cells, but
can also occur in any metabolically active tissue such as brain, liver,
reticulo-endothelial, and even inﬂammation. Both infection and in-
ﬂammation are known causes of false-positive scan results. In our pa-
tient, it is possible that her clinically enlarged lymph nodes were
secondary to vulvar or vaginal bacterial infection, given the large size
of the tumor and likely areas of necrosis. Other potential causes for a
false positive PET–CT scan include: active ﬁbrosis, granulomatosis,
sarcoidosis, hemangiomas or even ectopic endocrine tissue. Therefore,
PET positivity is not speciﬁc to malignant cells. The combination of
PET and CT scanning can increase speciﬁcity as well as the positive pre-
dictive value (Schmidt et al., 2007). For detecting metastasis of vulvar
cancer, PET–CT is found to have a sensitivity of 80%, speciﬁcity of 90%,
positive predictive value of 80%, and negative predictive value of 90%
(Cohn et al., 2002). For detecting inguinofemoral lymph node metasta-
sis speciﬁcally, PET–CT has a sensitivity rate of 67%, speciﬁcity of 95%,
positive predictive value of 86%, and negative predictive value of 86%
(Cohn et al., 2002).
The positive and the negative prediction values of the PET–CT scan
in patients with clinically large and suspicious lymph nodes are un-
known, however. Most of our knowledge about the accuracy of the
PET–CT scan comes from vulvar cancer patients with normal sized
lymph nodes. Future studies to examine this particular matter are
needed. Until these values are determined, frozen section analysis
31L.J. Perry et al. / Gynecologic Oncology Reports 4 (2013) 29–31should be performed at the time of surgery for clinically suspicious
nodes.
In conclusion, this case illustrates that if further treatment man-
agement is dependent upon the presence of a positive lymph node,
it is imperative to obtain intraoperative frozen section analysis for
suspicious inguinofemoral lymph nodes, even if they are known to
be PET–CT scan positive. The possible future adoption of SLN dissec-
tion in vulvar cancer has the potential to limit the PET–CT scan to a
screening tool for distant metastasis only.Consent
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